Abstract: The widespread adoption of the fifth generation (5G) of cellular networks has brought new opportunities for the development of localization-based services. High-accuracy positioning use ...
PTC Therapeutics is transitioning its growth engine from legacy drugs to new launches like Sephience, targeting rare genetic diseases with high unmet need. Pipeline catalysts, notably Votoplam for ...